Cystic fibrosis Flashcards

1
Q

what is the definition of cystic fibrosis?

A

Cystic fibrosis (CF) is a severely life-shortening genetic disease resulting from abnormalities in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel found in cells lining the lungs, intestines, pancreatic ducts, sweat glands, and reproductive organs. There are over 2000 known disease-causing mutations that interrupt various stages of CFTR synthesis and function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the epidemiology of CF?

A

Higher incidence in white people

Incidence decreasing due to newborn screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the aetiology of CF?

A

CF is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel found in the apical membrane of epithelial cells. Patients may be either homozygous or heterozygous with respect to CFTR mutations. Carriers of one CFTR mutation and one normal CFTR allele usually do not demonstrate disease (autosomal recessive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the risk factors for CF?

A

Family history
Known carrier status of both parents
Ethnicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathophysiology of CF?

A

Mutations in CFTR result in abnormal salt transport by epithelial cells, resulting in thick, sticky secretions.
In the pancreas, this leads to blockage of exocrine ducts, early activation of pancreatic enzymes, and eventual autodestruction of the exocrine pancreas. Therefore, most patients require supplemental pancreatic enzymes.
In the intestine, bulky stools can lead to intestinal blockage.
In the respiratory system, the absence of CFTR function results in mucus retention, chronic infection, and inflammation that eventuate in the destruction of lung tissue. There are multiple hypotheses regarding the genesis of lung disease, each of which is supported by data in vitro and in vivo. Lung disease is the most common cause of morbidity and mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the key presentations for CF?

A
Risk factors 
Positive newborn screening 
Failure to pass meconium 
Failure to thrive 
Voracious appetite 
Wet-sounding cough 
Recurrent infection 
Chronic sinusitis 
Genital abnormalities in males - absent vas deferens 
steatorrhea
late puberty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the first line and gold standard investigations for CF?

A

Sweat test - positive (sweat chloride >60 mmol/L [≥60 mEq/L])
Immunoreactive trypsinogen test (newborn screening) - positive (value depends on units of measure and population norms)
Genetic testing - presence of two disease-causing mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the differential diagnoses for CF?

A

Primary ciliary dyskinesia
Primary immunodeficiency
Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how is CF managed?

A

Neonate with meconium ileus:
lactulose: consult specialist for guidance on dose, surgery, nasogastric decompression
Complete interesting obstruction:
Surgery, nasogastric decompression
Acute resp infection:
Mild: Oral antibiotic (amoxicillin/clavulanate: children: 45-90 mg/kg/day orally given in divided doses every 12 hours; adults: 875 mg orally every 12 hours), chest pysio, inhaler, mucolytic inhaler, non invasive ventilation, tobramycin inhaler
Moderate: IV antibiotics (tobramycin: children and adults: 3.3 mg/kg intravenously every 8 hours, or 10 mg/kg intravenously every 24 hours and ticarcillin/clavulanic acid: children: 400 mg/kg/day intravenously given in divided doses every 6 hours; adults: 4000 mg intravenously every 6 hours) + as above
Ongoing resp:
Chest physio, inhalers, NSAIDs, inhaler corticosteroids, CFTR modulator, non-invasive ventilation, oxygen, bilateral lung transplant
Ongoing GI:
Optimising nutrition, pancreatic enzyme replacement. H2 antagonist, fat soluble vitamin supplements, ursodeoxycholic acid, CFTR modulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how is CF monitored?

A

There is no cure, and therefore long-term care is a cornerstone of successful disease management. Patients should be seen by a CF care team at a CF centre at least once every 3 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the complications of CF?

A

Distal intestinal obstructive syndrome
Pneumothorax
Intussuscption
diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the prognosis of CF?

A

Survival rising. Around 40 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which chromosome is the mutation on in CF?

A

7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly